Back
Teladoc Health Quote, Financials, Valuation and Earnings
Sponsored
TDOC
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
28
TDOC
Teladoc Health
Last Price:
13.73
Seasonality Move:
16.49%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Teladoc Health Price Quote
$13.73
-0.01 (-0.07%)
(Updated: April 24, 2024 at 6:55 PM ET)
Teladoc Health Key Stats
Sell
28
Teladoc Health (TDOC)
is a Sell
Day range:
$13.31 - $14.05
52-week range:
$12.86 - $30.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.87
P/B ratio:
1%
Volume:
4M
Avg. volume:
4.3M
1-year change:
-50.56%
Market cap:
$2.3B
Revenue:
$2.6B
EPS:
$-1.34
How Much Does Teladoc Health Make?
-
How Much Are Teladoc Health's Sales Annually?
TDOC Revenues are $2.6B -
How Much Profit Does Teladoc Health's Make A Year?
TDOC net income is -$220.4M
Is Teladoc Health Growing As A Company?
-
What Is Teladoc Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04% -
What Is Teladoc Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Teladoc Health Stock Price Performance
-
Did Teladoc Health Stock Go Up Last Month?
Teladoc Health share price went down by -8.4% last month -
Did TDOC's Share Price Rise Over The Last Year?
TDOC share price fell by -50.56% over the past 1 year
What Is Teladoc Health 52-Week High & Low?
-
What Is Teladoc Health’s 52-Week High Share Price?
Teladoc Health has traded as high as $30.41 over the past 52 weeks -
What Is Teladoc Health’s 52-Week Low Share Price?
Teladoc Health has traded as low as $12.86 over the past 52 weeks
Teladoc Health Price To Free Cash Flow
-
Is Teladoc Health Stock Overvalued?
Teladoc Health is trading at a price to free cash flow ratio of 11.68 -
Is Teladoc Health Stock Undervalued?
Teladoc Health EV to Free Cash Flow ratio is 14.15 -
What Is Teladoc Health’s Price Earnings Growth Ratio?
TDOC PEG ratio is 0.00 -
Is Teladoc Health Trading At A Premium To Earnings?
Teladoc Health EV to EBIT ratio is 0.00
Is It Risky To Buy Teladoc Health?
-
How Much Debt Does Teladoc Health Have?
Total long term debt quarterly is $1.5B -
How Much Cash Does Teladoc Health Have?
Cash and short term investments quarterly total is $1.1B -
What Is Teladoc Health’s Book Value Per Share?
Book value per share is 13.96
Is Teladoc Health Cash Flow Positive?
-
What Is TDOC Cash Flow From Operations?
Cash flow from operations (TTM) is $350M -
What Is Teladoc Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.9M -
What Is Teladoc Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$156.3M
Teladoc Health Return On Invested Capital
-
Is Management Doing A Good Job?
TDOC return on invested capital is -5.74% -
What Is Teladoc Health Return On Assets?
ROA measures how assets are converting to revenues and is -5.08% -
What Is TDOC Return On Equity?
ROE is a measure of profitability and is -9.57%
Teladoc Health Earnings Date & Stock Price
-
What Is Teladoc Health's Stock Price Today?
A single share of TDOC can be purchased today for 13.74 -
What Is Teladoc Health’s Stock Symbol?
Teladoc Health trades on the nyse under the ticker symbol: TDOC -
When Is Teladoc Health’s Next Earnings Date?
The next quarterly earnings date for Teladoc Health is scheduled on April 25, 2024 -
When Is TDOC's next ex-dividend date?
Teladoc Health's next ex-dividend date is May 12, 2020 -
How To Buy Teladoc Health Stock?
You can buy Teladoc Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Teladoc Health Competitors
-
Who Are Teladoc Health's Competitors?
Below is a list of companies who compete with Teladoc Health or are related in some way:
Teladoc Health Dividend Yield
Data Unavailable
Teladoc Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 39.21% |
Revenue: | 3.58% | -1.57% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 21 |
Sell Recommendations: | 0 |
Price Target: | 19.51 |
Upside from Last Price: | 42.02% |